Pathophysiologic Changes in Extracellular pH Modulate Parathyroid Calcium-Sensing Receptor Activity and Secretion via a Histidine-Independent Mechanism by Campion, KL et al.







Pathophysiological Changes in Extracellular pH Modulate Parathyroid 




Katherine L Campion1, Wanda D McCormick1,2, Jim Warwicker1, 
Mohd Ezuan Bin Khayat1,3, Rebecca Atkinson-Dell1, Martin C Steward1, Leigh W Delbridge4, 
Hee-Chang Mun4, Arthur D Conigrave4, and Donald T Ward1 
 
1Faculty of Life Sciences, The University of Manchester, UK 
2Moulton College, Northamptonshire, UK 
3Dept. of Biochemistry, Faculty of Biotechnology & Biomolecular Sciences, 
Universiti Putra Malaysia, Selangor, Malaysia 
4School of Molecular Bioscience, University of Sydney, NSW 2006 Australia 
 
 
Running title: Calcium Receptor modulation by pHo 
 
To whom correspondence should be addressed: Donald T Ward, Faculty of Life Sciences, Michael Smith 
Building, The University of Manchester, Manchester, M13 9PT, United Kingdom, Tel.:+44 161 275 5459; 
Email: d.ward@manchester.ac.uk 
 
Keywords: Calcium-sensing receptor, Parathyroid Hormone, Acidosis, Mineral Metabolism
 
ABSTRACT 
The calcium-sensing receptor (CaR) modulates renal calcium reabsorption and parathyroid 
hormone (PTH) secretion and is involved in the aetiology of secondary hyperparathyroidism in 
CKD. Supraphysiological extracellular pH (pHo) changes modulate CaR responsiveness in HEK-293 
(CaR-HEK) cells. Therefore, since acidosis and alkalosis are associated with altered PTH secretion 
in vivo, we examined whether pathophysiological changes in pHo can alter CaR responsiveness 
significantly in both heterologous and endogenous expression systems and whether this affects PTH 
secretion. 
    In both CaR-HEK and isolated bovine parathyroid cells, decreasing pHo from 7.4 to 7.2 rapidly 
inhibited CaR-induced intracellular calcium (Ca2+i) mobilization while raising pHo to 7.6 
potentiated extracellular calcium (Ca2+o) responsiveness. Similar pHo effects were observed for 
Ca2+o-induced extracellular signal-regulated kinase phosphorylation and actin polymerization and 
for L-Phe induced Ca2+i mobilization. Intracellular pH was unaffected by acute 0.4 unit pHo changes 
while the presence of physiological albumin concentrations failed to attenuate the pHo effects. CaR 





pHo-sensitivity does not result from extracellular histidine or free cysteine ionization since point 
mutations of none of 17 such residues attenuated pHo sensitivity. Finally, pathophysiological pHo 
elevation reversibly suppressed PTH secretion from perifused human parathyroid cells, and 
acidosis transiently increased PTH secretion.   
    Therefore, pathophysiological pHo changes can modulate CaR responsiveness in HEK-293 and 
parathyroid cells, independently of extracellular histidine residues. Specifically, pathophysiological 
acidification inhibits CaR activity thus permitting PTH secretion, whereas alkalinization potentiates 
CaR activity to suppress PTH secretion. These findings suggest that acid-base disturbances may 
affect the CaR-mediated control of parathyroid function and calcium metabolism in vivo.   
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Mammalian calcium homeostasis is maintained by the regulated secretion of parathyroid hormone (PTH) 
and renal calcium reabsorption under the control of the calcium-sensing receptor (CaR) (1,2). 
Hypercalcaemia stimulates the CaR to suppress PTH secretion while chronic underactivation of CaR can 
contribute to pathologically elevated PTH secretion such as in secondary hyperparathyroidism of chronic 
kidney disease (CKD). In a heterologous human embryonic kidney (HEK)-293 cell-based expression 
system, Quinn et al (3) found that the Ca2+o potency of the human CaR is sensitive to supraphysiological 
changes in extracellular pH (pHo). By varying the pH of the experimental buffer in 0.5 unit steps from 5.5 
to 9, the sensitivity of CaR to Ca2+o (and Mg
2+
o) was altered with external acidification decreasing CaR 
sensitivity and alkalinisation increasing CaR sensitivity (3). However, blood pH levels (7.35-7.45 ≈ 40nM 
H+ concentration) rarely vary beyond ± 0.4 pH units in vivo even under extreme pathological conditions, 
with even smaller changes (± 0.2) more generally seen, such as with the acidosis of CKD however even 
this still represents a ~58% increase in H+ concentration. Secondary hyperparathyroidism is another 
complication of CKD and interestingly in animal experiments, induction of metabolic acidosis results in 
increased serum PTH levels and hypercalcaemia, whereas induction of alkalosis suppresses serum PTH 
levels (4-8).  
 





Therefore, since acidosis has been associated with increased serum PTH levels in vivo, we examined 
whether much smaller, pathophysiologically relevant changes in pHo (± 0.2) can alter the Ca
2+
o sensitivity 
of CaR-mediated signaling pathways in HEK-293 cells and whether such effects can be replicated in 
parathyroid cells. We also examined whether a specific histidine or free cysteine residue could account for 




Fura 2-loaded CaR-HEK cells were stimulated with 2.5mM Ca2+o (pH 7.4) to elicit CaR-induced Ca
2+
i 
mobilisation and then switched to the same buffer at either pH 7.2 or 7.6 before being returned to pH 7.4. 
At pH 7.6, CaR responsiveness (i.e. 350/380 fura ratio area under the curve) was significantly increased 
(Fig.1A), an effect that was immediately reversible upon return to pH 7.4. In contrast, lowering pHo to 7.2 
significantly inhibited CaR responsiveness (Fig.1B), the effect being immediately reversible. The effect of 
± 0.2 pH unit changes on Ca2+i mobilization was then tested over a range of Ca
2+
o concentrations from 0.5-
10 mM. Again, CaR responsiveness was significantly inhibited in pH 7.2 (EC50 for Ca
2+
o, 3.6 ± 0.2 mM in 
7.2 vs. 3.1 ± 0.1 in 7.4, P<0.05) and significantly stimulated in pH 7.6 (2.8 ± 0.0 mM in 7.6, P<0.05). In 
addition, similar effects of changing pHo (± 0.2 units) were also seen using bicarbonate/CO2 buffers 
(Fig.1D).  
 
To determine whether this apparent pHo-sensitivity of CaR is specific to intracellular Ca
2+
i mobilisation or 
applies to other effector pathways, two other readouts of CaR activity were used; namely extracellular 
signal-regulated kinase (ERK) phosphorylation  and actin polymerization (9, 10). Indeed, mild acidosis 
(pHo 7.2) significantly inhibited Ca
2+
o-induced ERK phosphorylation in CaR-HEK cells (Fig.2A; 3.5 mM 
Ca2+o), while mild alkalosis (pHo 7.6) increased ERK activation. Similarly a 0.2 unit reduction in pHo 
inhibited 1.5 mM Ca2+o-induced actin polymerisation while a 0.2 unit increase in pHo potentiated 1.8 mM 
Ca2+o-induced actin polymerisation (Fig.2B). Together these results suggest that the effect of altering pHo 
affects the Ca2+o sensitivity of the CaR rather than the mechanism of Ca
2+
i mobilization. Indeed, in the 





presence of 0.5 mM Ca2+o (which renders the CaR inactive) variations in pHo between 7.2 and 7.6 had no 
effect on actin polymerisation indicating that changing pHo does not otherwise affect baseline signalling. 
Next, we examined the effect of 0.2 unit pHo changes on the response to the CaR positive allosteric 
modulator L-Phe (10 mM) to determine whether the pHo sensitivity is exclusive to orthosteric agonism 
with Ca2+o. We observed significant potentiation of L-Phe-induced Ca
2+
i mobilization in pHo 7.6 and 




Next, we examined whether pathophysiological changes in pHo also affect CaR-induced Ca
2+
i mobilisation 
in parathyroid cells, in which the CaR is expressed endogenously. Indeed, raising pHo to 7.6 while 
stimulating CaR-induced Ca2+i mobilization in bovine parathyroid cells (2.5mM Ca
2+
o) significantly 
potentiated the response, an effect that was fully and immediately reversible upon return to pHo 7.4 
(Fig.3A). In addition, lowering pHo to 7.2 promptly inhibited the Ca
2+
i mobilization elicited in parathyroid 
cells in response to 2.5mM Ca2+o (Fig.3B). 
 
In considering the potential (patho)physiological relevance of CaR pHo-sensitivity, it should be noted that 
serum albumin can bind calcium in a pH-dependent manner. Thus, albumin releases calcium under acidic 
conditions, which might tend to counteract the concomitant CaR inhibition, whereas alkaline conditions 
promote calcium binding to albumin and thus potentially counteract the CaR stimulation. In consequence, 
we tested the effects of pHo on CaR-induced Ca
2+
i mobilisation in the presence of a physiological 
concentration of albumin (5% w/v). Exposure of CaR-HEK cells to 3 mM Ca2+o (in 5% (w/v) albumin) at 
pH 7.4 resulted in an increase in Ca2+i concentration, and as before, lowering pHo to 7.2 resulted in a 
reversible attenuation of the CaR response (Fig.4Ai). In addition, increasing pHo to 7.6 while stimulating 
CaR with 3 mM Ca2+o (in 5% albumin) resulted in potentiation of the response (Fig.4Aii). This was further 
tested in bovine parathyroid cells and again raising pHo to 7.6 potentiated CaR activity despite the 
presence of 5% (w/v) albumin (Fig.4B). 
 
To test whether the changes in pHo might instead be acting by altering intracellular pH (pHi), CaR-HEK 
and bovine parathyroid cells were loaded with the pH-sensitive dye BCECF and exposed to CaR 





stimulation in the presence or absence of even greater changes in pHo, namely pH 7.0 for acidosis and pH 
7.8 for alkalosis. However, in neither cell type did either pHo 7 or 7.8 (or indeed CaR activation itself) 
affect pHi over the timescales employed (Fig.5). Therefore, these data suggest that the consequence of 
altering pHo on intracellular signalling is via an effect on the CaR per se. Ammonium chloride and sodium 
acetate were used as positive controls to demonstrate that pHi changes could be detected in the BCECF-
loaded cells. Indeed, ammonium chloride elicited intracellular alkalinisation in both cell-types, whereas 
sodium acetate induced a marked intracellular acidification in CaR-HEK cells and had a much smaller 
effect in bovine parathyroid cells. 
  
Effect of altered pHo on parathyroid hormone secretion 
Next, parathyroid hormone secretion was measured in human parathyroid cells where it was shown that in 
the presence of physiological free Ca2+o concentration (1.2 mM), lowering pHo (7.2 then 7.0) caused an 
initial increase in PTH secretion whereas raising pH (7.6 then 7.8) suppressed PTH secretion (Fig.6). 
When pHo was lowered to normal (7.4), PTH secretion then rose again suggesting that the suppression 
was fully reversible. Preliminary experiments investigating the effect of 0.4 unit pHo changes on PTH 
secretion from both bovine and human parathyroid cells (and conducted prior to those shown in Fig.6) 
showed a similar pHo sensitivity, with alkalosis suppressing PTH secretion significantly in both cases (not 
shown).  
 
Investigation of extracellular histidine / cysteine residues as possible sites of CaR pHo sensitivity 
Finally, modelling the homodimeric CaR extracellular domain using sequence alignment with the 
metabotropic glutamate receptor (mGlu) structure 2e4u (11,12) revealed the proximity of certain 
extracellular histidine sites (in black) to clusters of aspartate and glutamate residues (in grey) previously 
proposed to be sites of Ca2+o binding (13,14) (Fig.7A). The amino acids whose sidechain pK values are 
closest to the physiological pHo and thus that might account for pHo-sensitivity in CaR, are histidine 
(~6.5) and free cysteine (~8.5). Indeed the human CaR contains 16 extracellular histidines plus 1 free 
cysteine residue (Cys-482). Therefore, each of these residues was mutated individually, histidines to 
valines and the cysteine to serine, with the resulting 17 CaR mutants expressed transiently in HEK-293 





cells. The effects of ± 0.2 pHo unit changes on CaR-induced Ca
2+
i mobilization were then tested in the 
mutant CaR-expressing cells and compared to their effects on wild-type CaR-expressing cells. For this, 
concentration-effect curves for Ca2+o-induced Ca
2+
i mobilization were generated to determine whether the 
mutations elicit substantial changes in Ca2+o potency / CaR responsiveness per se. All but two of the 
mutants exhibited significant, sigmodial Ca2+o sensitivity (at concentrations <10mM), the exceptions being 
CaRH41V and CaRH595V (Table 1).  
 
For the 15 CaR mutants that exhibited robust Ca2+o sensitivity, the effect of ± 0.2 pHo unit changes on 
CaR-induced Ca2+i mobilization was then tested following exposure to 3.5 mM Ca
2+
o. There were no 
significant reductions in either acidosis-elicited attenuation or alkalosis-mediated potentiation of CaR 
activity in any of the CaR mutants (relative to wild-type CaR) suggesting that none of them contribute to 
pHo sensitivity in CaR (Table 1). Having failed to identify a sole histidine residue as being responsible for 
eliciting CaR pHo sensitivity, the two histidine mutants that produced the largest trend reductions in pHo 
sensitivity, namely CaRH429V and CaRH495V, were then co-mutated to determine whether together they 
might inhibit CaR pHo sensitivity. However, the pHo sensitivity of CaR
H429V/H495V was not significantly 
different from wild-type CaR. 
 
For the two remaining mutants that exhibited reduced Ca2+o sensitivity (and lower protein abundance of 
the mature 160kDa CaR protein), more robust stimulation was required, namely 5 mM Ca2+o plus 1 M 
R467 (positive allosteric modulator) for CaRH595V and 30 mM Ca2+o plus 1 M R467 for CaR
H41V (Fig.7B, 
Table 1). Since these treatments represent supramaximal stimuli for wild-type CaR, and thus are 
unsuitable for testing the effects of altering pHo on the wild-type receptor, the resulting data for CaR
H41V 
and CaRH595V cannot be compared directly to wild-type CaR but are appropriate for qualitative comparison 
by examining their signalling before and after the change in pHo. In the case of both mutations, lowering 
pHo significantly inhibited the CaR response while raising pHo significantly increased activity in the 
mutant CaRs as before. Therefore taken together, there was no evidence that any of the 17 histidine 
residues or single free cysteine (Cys-482) contributed to the pHo sensitivity of CaR.  







Ca2+o potency for CaR is known to be sensitive to large changes in ambient pHo (3,15). The pH of human 
plasma is maintained between 7.35 and 7.45 representing a 12.5% deviation above and below the normal 
H+ concentration of 4x10-8 M (i.e., pH 7.40). Indeed, a 1-unit pH change would represent a lethal ten-fold 
change in H+ concentration (16), and even a smaller drop to 7.1 and below represents a medical 
emergency. This led us to investigate whether the CaR can also respond to smaller, pathophysiologically 
relevant changes in pHo. Since metabolic acidosis and secondary hyperparathyroidism are both common 
consequences of CKD, the current data may even provide a mechanistic link between the two. 
 
Here we have demonstrated that pathophysiologically-relevant (0.2 unit) changes in pHo modulate 
significantly Ca2+o-induced Ca
2+
i mobilization in CaR-HEK cells and elicit similar effects on two other 
readouts of CaR-mediated signalling, namely ERK phosphorylation and actin polymerisation. Thus, the 
effect of the pHo change is not signalling pathway-specific and thus likely occurs at the level of the CaR. 
Indeed, no acute changes in pHi were detected in either CaR-HEK or bovine parathyroid cells following 
exposure to larger (0.4 unit) changes in pHo over the timescale tested, supporting the idea that the change 
in pHo elicits an extracellular, as opposed to non-specific intracellular, effect on CaR activity. Quinn et al 
(3) reported slow cytoplasmic acidification / alkalinisation in CaR-HEKs in response to much larger 1-2 
pHo unit decreases / increases respectively, however the slow rate of change failed to account for the 
much more rapid pHo-mediated change in CaR sensitivity.  
 
Regarding the CaR agonist selectivity of the pHo effect, Quinn et al (3) found that Mg
2+
o was similarly 
affected by pHo as for Ca
2+
o, both of these cations being orthosteric CaR agonists. Here we found that L-
Phe-induced Ca2+i mobilization was also sensitive to pathophysiological changes in pHo suggesting that 
allosteric CaR modulation is similarly sensitive to pHo and thus unlikely to counteract the effect in vivo. 
 
Importantly, the enhancement of CaR signalling in pHo 7.6 and inhibition in pHo 7.2 was also observed in 
bovine parathyroid cells, in which the CaR is expressed endogenously. Consistent with this observation 





was the clear suppression of PTH secretion from bovine and human parathyroid cells following perifusion 
in alkaline buffer (pHo 7.8; preliminary experiments not shown). Repeating these experiments using 0.2 
unit pHo changes, we observed a transient rise in PTH secretion from human parathyroid cells which was 
not sustained when pHo was lowered to 7.2, and, more sustained suppression of PTH secretion when pHo 
was increased to 7.6. These in vitro data are consistent with observations that metabolic acidosis is 
associated with increased serum PTH and calcium levels and that alkalosis suppresses serum PTH in vivo 
(4,6-8). The current findings suggest a CaR-based mechanism for these previous data from animal studies. 
It will be interesting therefore to determine therefore whether acidosis and/or alkalosis elicit chronic 
changes in PTH secretion in vivo. Interestingly, at age 80, human blood H+ concentration is 6-7% higher 
than at age 20 (17) and there is a concomitant rise in serum PTH levels (18). With regards to metabolic 
acidosis and secondary hyperparathyroidism in CKD, while secondary hyperparathyroidism is known to 
be due partly to hyperphosphatemia and partly to decreased calcitriol levels (resulting in part to lowered 
plasma free calcium concentration), it is interesting to speculate that acidosis may also contribute to 
elevated PTH secretion rates by suppressing CaR-sensitivity as observed here. In addition, the current data 
suggest that raising pHo promotes CaR-mediated suppression of PTH secretion and thus may provide the 
basis of a useful adjuvant therapy for secondary hyperparathyroidism in chronic kidney disease. Indeed 
clinically, low bicarbonate concentration in pre-dialysis patients predicts subsequent coronary artery 
calcification (19). Since oral sodium bicarbonate supplementation slows the rate of decline of renal 
function in CKD patients with low plasma bicarbonate concentrations (20) the effect of this co-therapy on 
the development of secondary hyperparathyroidism and vascular calcification might be considered for 
investigation. Interestingly, acidosis also increases fibroblast growth factor (FGF)23 expression in 
osteoblasts raising the question of whether treating acidosis in CKD may lower FGF23 (21) and indeed 
PTH secretion.   
 
Low pH displaces bound calcium from serum albumin and could compensate for the acid-mediated 
decline in CaR responsiveness by increasing the free calcium concentration (22). However, in the current 
study, inclusion of 5% (w/v) albumin in the physiological saline solution, i.e., at a physiologically relevant 
concentration, had little or no effect on the pHo-sensitivity of the CaR. Indeed, albumin was present in 





both sets of experiments measuring human and bovine PTH secretion and this did not prevent detection of 
an alkalosis-induced suppression of PTH secretion. Thus, over the pathophysiological pHo range, the 
effect of changing pHo on CaR activity appears greater than any potential effect on calcium-buffering / 
displacement. Indeed, one study found that between pH 6.8 and 7.4, the calcium-binding affinity of 
albumin is not altered significantly whereas at pH 8, there is a four-fold increase in the association 
constant (23). 
 
Extracellular histidine residues have been shown to account for proton sensitivity in a number of 
membrane proteins including the anion exchange protein 2 (24), ovarian cancer G protein-coupled 
receptor-1 (25) and purinergic P2X4 receptor (26,27). Despite this, we found no evidence that any of the 
16 extracellular histidine residues or the one free-cysteine residue (Cys-482) are individually responsible 
for CaR pHo sensitivity, at least over the pathophysiological pHo range tested. Amongst members of the 
homologous family C GPCRs, mGluR4 is also inhibited by acidity and activated by alkalinity whereas 
mGluRs 1, 5 and 8 are pHo-insensitive (28). However, no histamines are shared exclusively between CaR 
and mGluR4. Therefore we conclude, by exclusion, that the most likely molecular mediators of CaR pHo 
sensitivity are extracellular clusters of aspartate and glutamate residues (3). That is, despite the low pKa 
values of Glu and Asp side-chains in their free amino acid forms (around 4), when clustered, their pKa 
values may lie closer to the physiological pH range (~7) (29,30). Finally, while we cannot rule out the 
possible contribution of other pHo-sensitive membrane proteins to these data, it should be noted that the 
pHo changes were without effect in cells either lacking the CaR (not shown), or, incubated in low Ca
2+
o 
concentration (Fig.2Bii).  
 
In conclusion, the human CaR exhibits pHo sensitivity over the pathophysiological range of pHo witnessed 
in vivo. This pHo sensitivity of the CaR exerts functionally significant effects on PTH secretion and thus 
might have wider relevance for whole body calcium homeostasis and indeed for the secondary 
hyperparathyroidism of CKD. 
 
 





CONCISE METHODS   
Cell Culture and Calcium-Sensing Receptor functional assays 
HEK-293 cells, stably transfected with human parathyroid CaR, were cultured in Dulbecco’s Modified 
Eagle's medium (supplemented with 10% v/v fetal bovine serum), loaded with  Fura-2/AM and assayed 
for Ca2+i by dual-excitation wavelength microfluorometry in Experimental Buffer [20mM HEPES, pH 7.4, 
125mM NaCl, 4mM KCl, 1.2mM CaCl2, 0.5mM MgCl2, 5.5mM glucose] as described previously (10). 
Intracellular pH was quantified similarly using the pH-sensitive fluorescent dye BCECF. CaR-induced 
ERK phosphorylation was detected by semi-quantitative immunoblotting using a phospho-specific 
polyclonal antibody (9) against the lysates of cells solubilised in RIPA buffer supplemented with protease 
and phosphatase inhibitors. To assess actin stress fiber assembly, paraformaldehyde-fixed cells were 
stained with Phalloidin-TRITC and imaged by fluorescence microscopy (10).  
Site-directed mutagenesis – CaR mutations were introduced into the human CaR by QuikChange 
(Stratagene) site-directed mutagenesis then transiently transfected into HEK-293 cells using FuGENE-6. 
Parathyroid gland preparation and PTH secretion assay - Bovine parathyroid cells (abattoir-sourced) 
were obtained by collagenase-digestion (9) and cultured on collagen-coated coverslips. Normal human 
parathyroid cells were obtained by collagenase-digestion following neck surgery (9; procedures performed 
under institutional ethical guidelines and with patients’ written informed consent). PTH levels were 
quantified by ELISA following perifusion with buffer containing (mM) 125 NaCl, 4 KCl, 1.25 CaCl2, 1 
MgCl2, 0.8 Na2HPO4, 20 HEPES (pH 7.4, NaOH) supplemented with 0.1% D-glucose, 2.8mM basal 
amino acid mixture (defined previously (9)) and 1 mg/ml bovine serum albumin. 
Statistical analysis - Data are presented as means ± S.E. and statistical significance determined using 
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 FIGURE LEGENDS 
 
 
FIGURE 1. Effect of changes in pHo on CaR-induced Ca
2+
i mobilisation in CaR-HEK cells. A) 
Representative trace showing Ca2+i changes (Fura-2 ratio) in a single cell (upper trace, “cell”) and “global” 
(lower trace) cluster of (>10) cells in response to elevated [Ca2+]o (2.5 vs 0.5mM control) when pHo was 
changed from 7.4 to 7.6. Changes in [Ca2+]i shown as % control of the area under the curve. n=4 
coverslips; B) Identical except testing the effect of decreased pHo (7.2). n=4 coverslips; *P<0.05, 
***P<0.001  vs first pH 7.4 treatment; +++P<0.001 vs pH 7.6 treatment by repeated measures ANOVA 
(Tukey post-test) performed on the raw data. C) Cells were exposed to buffers containing increasing 
concentrations of Ca2+o (0.5-10 mM) in either pHo 7.2, 7.4 or 7.6 with the resulting concentration-effect 
curves for Ca2+i mobilization shown (left) together with their EC50s (right). While the EC50 values were 
significantly different, the maximal responses were not significantly different, despite the apparent trend.  
*P<0.05 vs pH 7.4 by repeated measures ANOVA (Dunnett’s) performed on log EC50 values from 4 
independent experiments (2-5 coverslip replicates per data point, >15 cells per coverslip). D) Similar 
results were obtained using bicarbonate / CO2 buffers, with pH 7.6 increasing Ca
2+
i mobilisation and pH 
7.2 decreasing mobilisation in a single cell (upper trace) and “global” cluster of (>10) cells (lower trace) 
in response to 2.5 mM Ca2+o as before. Relative changes in [Ca
2+]i are shown in the bar graph. The 
appropriate pHs were obtained by varying the bicarbonate (and NaCl) concentrations in buffers gassed 
continuously with 5%CO2/95%O2 (g). *P<0.05 vs pH 7.4 treatment by one-tailed paired t-test; n=7 
coverslips. 
 
FIGURE 2. Effect of pHo on CaR-induced ERK activation, actin polymerization and L-Phe 
responsiveness in CaR-HEK cells. A) Representative immunoblot showing ERK phosphorylation 
(pERK) following treatment with 3.5mM Ca2+o for 10-min under different pHo conditions (7.4 ± 0.2). 
Mean changes in ERK phosphorylation were determined by densitometry and expressed on a bar graph in 
arbitrary units. n=9; *P<0.05, **P<0.01 vs pHo 7.4 by one-way ANOVA (Dunnet’s). B) Representative 
immunofluoresence images (i) showing phalloidin-TRITC staining following CaR-HEK treatment with 
1.5 mM Ca2+o for 3 hours in buffers of pHo ranging from 7.2 to 7.6. Quantification presented on a bar 
graph as pixels (Phalloidin-TRITC) per unit area in five randomly selected regions of the cells is shown 
below (iii). Also shown are bar graphs from separate experiments where the cells were exposed to either 
0.5 (ii) or 1.8 (iv) mM Ca2+o. n≥5; *P<0.05, **P<0.01 vs pHo 7.4 by one-way ANOVA (Dunnet’s). C) 
Representative Ca2+i trace (i) showing CaR-HEK cells stimulated first with 10mM L-Phe (in 1.8 mM 
Ca2+o) and then with 3 mM Ca
2+
o under various pHo conditions as shown (0.5 Ca
2+
o, baseline, pH 7.4 
unless otherwise stated). The traces include a typical response in a single cell (grey) as well as the total 
response in the cell cluster (>10 cells; “global”, black). Quantification (panel ii) is shown as a bar graph 





(% change in L-Phe responsiveness relative to pHo 7.4 control). n=7; **P<0.01 by Repeated Measures 
ANOVA, (Bonferroni’s). 
 
FIGURE 3. Effect of pHo on CaR-induced Ca
2+
i mobilization in parathyroid cells. A) Trace showing 
Ca2+i changes (quantified as a bar graph, as before) in a single cell (upper trace; “cell”) or the “global” 
(lower trace) cluster of cells in the field of view, in response to elevated [Ca2+]o (2.5 vs 0.8mM control) at 
pHo 7.4 or 7.6 (resulting changes normalised to pH 7.4 control). B) Identical experiment except examining 
the effect of lowering pHo (7.2) during CaR stimulation. n=6-8 coverslips; *P<0.05, **P<0.01 vs initial 
pH 7.4 response; ++P<0.01 vs pH 7.6 by Kruskal-Wallis (Dunn’s post-test). 
 
FIGURE 4. Physiological albumin concentration fails to prevent changes in pHo from modulating 
CaR activity. A) Changes in CaR-HEK cell Ca2+i concentration (measured as before) in a single cell or 
the “global” cluster of cells in response to elevated [Ca2+]o (3 vs 0.5 mM control) in buffer supplemented 
with 5% (w/v) BSA at either pHo 7.6 (i) or 7.2 (ii). The resulting changes (area under the curve) are 
normalised to pH 7.4 control and displayed as a bar graph. B) Identical experiment except using bovine 
parathyroid cells (2.5 vs 0.8mM control at pHo 7.4 or 7.6). n≥5 coverslips; *P<0.05, **P<0.01 vs initial 
pH 7.4 response; +P<0.05 vs pH 7.6 (or 7.2) by Kruskal-Wallis (Dunn’s). 
 
FIGURE 5. Effect of acute pHo changes on pHi in CaR-HEK and parathyroid cells. Ai) Trace showing 
pHi changes (BCECF ratio) in a cluster of CaR-HEK cells in response to elevated [Ca
2+]o (2.5 vs 0.5mM 
control) at pHo 7.4 and 7.8. Ammonium chloride (20mM, NH4Cl2) was used as a positive control. 
Quantification comparing control (baseline extrapolated) and treated (actual) values for calculated pHi. 
Aii) Identical experiment except examining the effect of lowering pHo (7.0) and with sodium acetate 
(20mM, NaAc) used as positive control. Bi) Trace showing pHi changes (BCECF ratio) in a cluster of 
bovine parathyroid cells in response to elevated [Ca2+]o (2.5 vs 0.8mM control) at pHo 7.4 and 7.8 (NH4Cl 
positive control). Bii) Identical experiment except examining the effect of lowering pHo (7.0). n=3-7 
coverslips. No significant change (by paired t-test) in pHi occurred following acute changes in pHo in 
either cell type. 
 
FIGURE 6. Extracellular pH modulates CaR-induced suppression of PTH secretion. Human 
parathyroid cells were perifused in 1.2 mM calcium-containing buffers at pHo 7.0-7.8 (at 5-min intervals) 
and PTH secretion quantified as fg per min per cell (A). Quantification of these changes is shown as % 
control in panel B. N=3 independent experiments; *P<0.05 by unpaired t-test (1-tail) on PTH values 
following preliminary experiments investigating the effect of 0.4 unit pHo changes on both human and 
bovine parathyroid cells (not shown). 
FIGURE 7. CaR extracellular domain model showing histidine and free cysteine residue locations 
relative to aspartate and glutamate clusters. A) Histidines and the free cysteine are shown in black with 
the three aspartate / glutamate clusters in light grey (21,22). Not shown are residues CaRH377 and CaRH766 
(located in a transmembrane extracellular loop). B) Immunoblots showing the mutant CaR proteins 
lacking each of the 17 extracellular histidine or free cysteine residues CaR immunoblots compared to 
wild-type (wt) CaR and -actin loading controls. 
 
  

















WT-CaR 4.3 ± 0.3 100 ± 19 16 -20 ± 2 14 ± 3 20 
H134V 4.3 ± 0.3 93 ± 19 6 -22 ± 6 9 ± 4 9 
H192V ***7.6 ± 1.0 118 ± 16 5 -22 ± 9 34 ± 13 7 
H254V 3.9 ± 0.6 90 ± 22 6 -10 ± 5 35 ± 9 6 
H312V 3.3 ± 0.5 80 ± 8 5 -26 ± 5 32 ± 10 6 
H338V 5.7 ± 0.1 162 ± 17 4 -22 ± 7 16 ± 4 6 
H344V * 6.1 ± 0.5 82 ± 6 8 -38 ± 10 55 ± 26 6 
H359V 5.2 ± 0.5 152 ± 22 8 -24 ± 13 11 ± 5 6 
H377V 5.8 ± 0.7 143 ± 11 8 -43 ± 6 19 ± 12 7 
H413V 3.9 ± 0.4 104 ± 20 5 -16 ± 9 13 ± 3 9 
H429V 5.7 ± 0.7 91 ± 11 3 -13 ± 13 9 ± 3 7 
H463V 5.9 ± 1.1 90 ± 13 6 -40 ± 5 23 ± 6 6 
H463V/H466V 4.7 ± 0.3 70 ± 9 9 -17 ± 8 21 ± 5 7 
H495V 4.8 ± 0.6 180 ± 52 3 -11 ± 7 11 ± 6 8 
H766V 3.3 ± 0.2 131 ± 9 9 -22 ± 4 20 ± 8 9 
C482S 3.7 ± 0.7 81 ± 39 3 -36 ± 5 26 ± 8 7 
H429V/H495V 5.0 ± 0.4 53 ± 7 7 -35 ± 4 19 ± 5 7 
H41V >10 - 9 -43 ± 6 22 ± 11 8 
H595V >10 - 9 22 ± 7 13 ± 5 9 
 
TABLE 1. Characterization of the Ca2+o-sensitivity, relative maximal responses and pHo sensitivity 
of the CaR histidine and free cysteine mutants versus wild-type.  Two independent series of 
experiments tested a) the Ca2+o-senstivity and maximal response (shown to the left of the thick vertical 
line) for each CaR mutant (extracellular histidine or free cysteine residues replaced with valine or serine 
respectively) versus wild-type (wt)  and also b) the effect of decreasing or increasing pHo by 0.2 units on 
receptor responsiveness (as shown to the right of the line). All but 4 of the CaR mutants exhibited Ca2+o 
sensitivity not significantly different from wild-type (WT) CaR. For CaRH192V and CaRH344V the EC50 
values for Ca2+o (mM) were increased significantly. *P<0.05, ***P<0.001 by one-way ANOVA, 
Dunnett’s post-hoc test. Regarding maximal responsiveness to Ca2+o (Emax), none of these CaR mutants 
responded differently to wild-type (Kruskal-Wallis, Dunn’s multiple comparison test) with the exception 
of CaRH41V and CaRH595V that required additional cotreatment with a positive allosteric modulator (1mM 
R-467) to achieve robust Ca2+i mobilisation (not shown). Next, none of the mutants exhibited significantly 
altered CaR pHo sensitivity (1-way ANOVA with Dunnett’s; ns, not significant) in response to either 
pathophysiological alkalosis (pHo 7.6) or acidosis (pHo 7.2) in the presence of 3.5mM Ca
2+
o. Since 
CaRH41V and CaRH595V lacked responsiveness to 3.5mM Ca2+o, the % change values quoted for them are 
not directly relative to wild-type CaR, but merely represent the % change of their CaR response from the 
immediately prior response in pH 7.4.  
